Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Financing Activities ₹29 Cr₹4.30 Cr₹5.84 Cr₹19 Cr₹-3.69 Cr

What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH is ₹29 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Financing Activities
Mar2023₹29 Cr
Mar2022₹4.30 Cr
Mar2021₹5.84 Cr
Mar2020₹19 Cr
Mar2019₹-3.69 Cr

How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2023 ₹29 Cr
577.69
Mar2022 ₹4.30 Cr
-26.39
Mar2021 ₹5.84 Cr
-69.37
Mar2020 ₹19 Cr
Positive
Mar2019 ₹-3.69 Cr -

Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹610.3 Cr -7.3% -17% -28.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹350,195.0 Cr -1.8% -2.9% 52.3% Stock Analytics
CIPLA ₹118,275.0 Cr -1.4% 4.5% 57% Stock Analytics
DIVIS LABORATORIES ₹117,130.0 Cr 7% 10.3% 26.7% Stock Analytics
ZYDUS LIFESCIENCES ₹102,998.0 Cr -4.9% 7.3% 105.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,034.1 Cr 0.2% -5.3% 32.4% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-7.3%

-17%

-28.9%

SENSEX

-2%

-1.1%

19.4%


You may also like the below Video Courses